外科學科

Medicine & Life Sciences

1. Meta-Analysis 100%
2. Taiwan 70%
3. Randomized Controlled Trials 68%
4. Neoplasms 67%
5. Breast Neoplasms 62%
6. Systematic Reviews 56%
7. Apoptosis 53%
8. Therapeutics 49%
9. Traumatic Brain Injury 49%
10. Colorectal Neoplasms 47%
11. Neoplasm Metastasis 39%
12. Hepatocellular Carcinoma 39%
13. Wounds and Injuries 39%
14. Confidence Intervals 37%
15. Rectal Neoplasms 33%
16. Colonic Neoplasms 32%
17. Robotics 29%
18. Glioblastoma 29%
19. Neoplastic Stem Cells 28%
20. Population 27%
21. Down-Regulation 27%
22. glucose-regulated proteins 27%
23. Catenins 26%
24. Cell Movement 25%
25. Cohort Studies 25%
26. Glioma 24%
27. MicroRNAs 23%
28. Survival 23%
29. Proteins 23%
30. Nicotinic Receptors 23%
31. Autophagy 23%
32. In Vitro Techniques 22%
33. Nicotine 22%
34. Laparoscopy 22%
35. Cardiomegaly 21%
36. Cardiac Myocytes 21%
37. Odds Ratio 21%
38. Mortality 21%
39. Up-Regulation 20%
40. Lung Neoplasms 20%
41. Stem Cells 20%
42. Incidence 20%
43. Genes 20%
44. Databases 20%
45. Growth 19%
46. Recurrence 19%
47. Liver 19%
48. Pain 18%
49. Mesenchymal Stem Cells 18%
50. Drug Therapy 18%
51. Angiotensin II 17%
52. Breast 17%
53. Brain 17%
54. Oxidative Stress 17%
55. Inflammation 17%
56. pterostilbene 16%
57. Carcinogenesis 16%
58. Radiosurgery 16%
59. Epithelial-Mesenchymal Transition 16%
60. ovatodiolide 16%
61. Bariatric Surgery 15%
62. Reactive Oxygen Species 15%
63. Length of Stay 15%
64. Phosphatidylinositol 3-Kinases 15%
65. Triple Negative Breast Neoplasms 15%
66. Cell Proliferation 15%
67. Cell Line 15%
68. Appendectomy 15%
69. ErbB Receptors 14%
70. PubMed 14%
71. Surgeons 14%
72. Temozolomide 14%
73. Learning Curve 14%
74. Safety 14%
75. Gastric Bypass 13%
76. Curcumin 13%
77. Appendicitis 13%
78. Resveratrol 13%
79. Gastrectomy 13%
80. Stroke 13%
81. Vertebroplasty 13%
82. Compression Fractures 13%
83. Quality of Life 12%
84. Sleep 12%
85. p38 Mitogen-Activated Protein Kinases 12%
86. Pharmaceutical Preparations 12%
87. Biomarkers 12%
88. Heart 12%
89. Lung 12%
90. Platelet-Rich Plasma 12%
91. Glucose 12%
92. Non-Small Cell Lung Carcinoma 12%
93. Heterografts 12%
94. Cell Death 12%
95. Parkinson Disease 12%
96. garcinol 12%
97. Oxygen 12%
98. Serum 12%
99. Transplants 12%